|
WO2021081069A1
|
|
Compositions and methods for enhancing retinal ganglion cell development and pluripotent stem cell-derived three-dimensional tissue
|
|
WO2021072186A1
|
|
System and method for identifying, selecting and purifying particles
|
|
WO2021072213A1
|
|
Pregabalin for treatment of opioid use disorder
|
|
WO2021072006A1
|
|
System and method of using plasmonic nanoparticles for anti-counterfeit applications
|
|
WO2021061650A1
|
|
Apparatus and method for pulsed mode charge detection mass spectrometry
|
|
WO2021055830A1
|
|
Vasculogenic fibroblasts
|
|
WO2021055531A1
|
|
Syringe pump controller
|
|
US2021077492A1
|
|
Methods and compositions of treating pancreatic cancer
|
|
WO2021055565A1
|
|
Prolonged function of liver organoids as an in vitro model for the study of liver disease
|
|
WO2021050695A1
|
|
Devices and methods for modulating adma in blood
|
|
WO2021050408A1
|
|
Porous microstructures for ion storage in high capacity electrodes based on surface segregation-induced separation
|
|
US2021069687A1
|
|
Pdo or bmtz ligand for supported coordinated pt hydrosilylation catalysts
|
|
WO2021046369A1
|
|
Novel compositions for disrupting biofilms
|
|
WO2021041495A2
|
|
Method to maintain or enhance tissue
|
|
WO2021026335A1
|
|
Methods for identifying and treating urinary tract infections
|
|
WO2021022245A1
|
|
Glyphosate biosensor
|
|
WO2021021931A1
|
|
Materials and methods for treating friedreich's ataxia
|
|
WO2021016074A1
|
|
Technologies for needles with microchannels
|
|
US2021009672A1
|
|
Methods of treating or preventing liver fibrosis with inhibition of activins a & b
|
|
WO2020264090A1
|
|
Fibers, prepreg materials, compositions composite articles, and methods of producing composite articles
|
